KCNA3 and migraine disorder: The shortlisted drugs were flunarizine dihydrochloride (a calcium antagonist approved for use for the prevention of migraines) [50,51], econazole nitrate (an anti-fungal calcium antagonist) [52], and quinine hydrochloride dihydrate (an anti-malarial potassium channel blocker) [53].